| Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data M Sarangdhar, S Tabar, C Schmidt, A Kushwaha, K Shah, JE Dahlquist, ... Nature biotechnology 34 (7), 697-700, 2016 | 76 | 2016 |
| Dipeptidyl peptidase‐4 inhibitors moderate the risk of genitourinary tract infections associated with sodium‐glucose co‐transporter‐2 inhibitors GP Fadini, BM Bonora, S Mayur, M Rigato, A Avogaro Diabetes, Obesity and Metabolism 20 (3), 740-744, 2018 | 52 | 2018 |
| Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors GP Fadini, M Sarangdhar, F De Ponti, A Avogaro, E Raschi BMJ Open Diabetes Research and Care 7 (1), e000725, 2019 | 38 | 2019 |
| Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System GP Fadini, M Sarangdhar, A Avogaro BMJ Open Diabetes Research and Care 6 (1), e000475, 2018 | 38 | 2018 |
| The impact of marijuana on antidepressant treatment in adolescents: clinical and pharmacologic considerations SE Vaughn, JR Strawn, EA Poweleit, M Sarangdhar, LB Ramsey Journal of Personalized Medicine 11 (7), 615, 2021 | 36 | 2021 |
| Pharmacovigilance evaluation of the association between DPP-4 inhibitors and heart failure: stimulated reporting and moderation by drug interactions GP Fadini, M Sarangdhar, A Avogaro Diabetes Therapy 9, 851-861, 2018 | 21 | 2018 |
| Tumor lysis syndrome associated with monoclonal antibodies in patients with multiple myeloma: a pharmacovigilance study based on the FAERS database S Xia, H Gong, Y Zhao, L Guo, Y Wang, R Ma, B Zhang, M Sarangdhar, ... Clinical Pharmacology & Therapeutics 114 (1), 211-219, 2023 | 17 | 2023 |
| Pneumocystis jirovecii pneumonia associated with immune checkpoint inhibitors: a systematic literature review of published case reports and disproportionality analysis based on … S Xia, H Gong, Y Wang, L Liu, Y Zhao, L Guo, B Zhang, M Sarangdhar, ... Frontiers in pharmacology 14, 1129730, 2023 | 12 | 2023 |
| Spiking Neurons: Is coincidence-factor enough for comparing responses with fluctuating membrane voltage? M Sarangdhar, C Kambhampati Proceedings of the world congress on engineering 2, 2-4, 2008 | 12 | 2008 |
| Do antibody–drug conjugates increase the risk of sepsis in cancer patients? A pharmacovigilance study S Xia, YC Zhao, L Guo, H Gong, YK Wang, R Ma, BK Zhang, Y Sheng, ... Frontiers in Pharmacology 13, 967017, 2022 | 10 | 2022 |
| Rheumatic and musculoskeletal adverse events with immune checkpoint inhibitors: Data from the United States food and drug administration adverse event reporting system XN Pundole, M Sarangdhar, ME Suarez-Almazor Journal of Immunotherapy and Precision Oncology 2 (3), 65-73, 2019 | 10 | 2019 |
| A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis CY Tsai, T Saito, M Sarangdhar, M Abu-El-Haija, L Wen, B Lee, M Yu, ... Science translational medicine 15 (687), eabn2110, 2023 | 8 | 2023 |
| Therapeutic Opportunities for Intestinal Angioectasia‐Targeting PPARγ and Oxidative Stress M Sarangdhar, MB Yacyshyn, AR Gruenzel, MA Engevik, NL Harris, ... Clinical and Translational Science 14 (2), 518-528, 2021 | 7 | 2021 |
| System and method for data mining very large drugs and clinical effects databases B Aronow, M Sarangdhar, SC Tabar, AG Jegga US Patent 10,769,242, 2020 | 7 | 2020 |
| Association of pulmonary sepsis and immune checkpoint inhibitors: A pharmacovigilance study S Xia, H Gong, Y Zhao, L Guo, Y Wang, B Zhang, M Sarangdhar, ... Cancers 15 (1), 240, 2022 | 6 | 2022 |
| Spiking Neurons and Synaptic Stimuli: Neural Response Comparison Using Coincidence-Factor M Sarangdhar, C Kambhampati Advances in Electrical Engineering and Computational Science, 681-692, 2009 | 6 | 2009 |
| Spiking Neurons and Synaptic Stimuli: Determining the Fidelity of Coincidence-Factor in Neural Response Comparison. M Sarangdhar, C Kambhampati Engineering Letters 16 (4), 2008 | 6 | 2008 |
| Using systems biology-based analysis approaches to identify mechanistically significant adverse drug reactions: Pulmonary complications from combined use of anti-TNFα agents … M Sarangdhar, A Kushwaha, J Dahlquist, A Jegga, B Aronow AMIA Summits on Translational Science Proceedings 2013, 151, 2013 | 5 | 2013 |
| A numerical model for Hodgkin-Huxley neural stimulus reconstruction M Sarangdhar, C Kambhampati IAENG International Journal of Computer Science 38 (1), 89-94, 2011 | 5 | 2011 |
| Tumor lysis syndrome with CD20 monoclonal antibodies for chronic lymphocytic leukemia: signals from the FDA Adverse Event Reporting System S Xia, J Ma, E Raschi, R Ma, B Zhang, L Guo, Y Noguchi, M Sarangdhar, ... Clinical Drug Investigation 43 (10), 773-783, 2023 | 4 | 2023 |
Bruce AronowCincinnati Children's Hospital Medical Center; University of CincinnatiVahvistettu sähköpostiosoite verkkotunnuksessa cchmc.org